- Home
- COGT vs BFK Comparison
COGT vs BFK Comparison
Compare COGT & BFK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- BFK
- Stock Information
- Founded
- COGT 2014
- BFK N/A
- Country
- COGT United States
- BFK United States
- Employees
- COGT N/A
- BFK N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- BFK Finance Companies
- Sector
- COGT Health Care
- BFK Finance
- Exchange
- COGT Nasdaq
- BFK Nasdaq
- Market Cap
- COGT 545.3M
- BFK 436.4M
- IPO Year
- COGT 2018
- BFK N/A
- Fundamental
- Price
- COGT $4.37
- BFK $9.55
- Analyst Decision
- COGT Buy
- BFK
- Analyst Count
- COGT 7
- BFK 0
- Target Price
- COGT $14.17
- BFK N/A
- AVG Volume (30 Days)
- COGT 1.7M
- BFK 117.1K
- Earning Date
- COGT 05-06-2025
- BFK 01-01-0001
- Dividend Yield
- COGT N/A
- BFK 4.33%
- EPS Growth
- COGT N/A
- BFK N/A
- EPS
- COGT N/A
- BFK N/A
- Revenue
- COGT N/A
- BFK N/A
- Revenue This Year
- COGT N/A
- BFK N/A
- Revenue Next Year
- COGT N/A
- BFK N/A
- P/E Ratio
- COGT N/A
- BFK N/A
- Revenue Growth
- COGT N/A
- BFK N/A
- 52 Week Low
- COGT $3.72
- BFK $8.55
- 52 Week High
- COGT $12.61
- BFK $10.48
- Technical
- Relative Strength Index (RSI)
- COGT 34.56
- BFK 42.40
- Support Level
- COGT $4.12
- BFK $8.83
- Resistance Level
- COGT $5.09
- BFK $9.62
- Average True Range (ATR)
- COGT 0.54
- BFK 0.23
- MACD
- COGT -0.02
- BFK -0.01
- Stochastic Oscillator
- COGT 23.90
- BFK 58.54
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About BFK BlackRock Municipal Income Trust
Blackrock Municipal Income Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from regular U.S. federal income tax.